- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Acuson turns in strong financials
Ultrasound vendor Acuson of Mountain View, CA, released year-end financial results this month that showed double-digit growth in revenues and net income. The company credited the performance to momentum generated by its Sequoia and Aspen products, as
Ultrasound vendor Acuson of Mountain View, CA, released year-end financial results this month that showed double-digit growth in revenues and net income. The company credited the performance to momentum generated by its Sequoia and Aspen products, as well as a robust U.S. market.
For the year (end-December), Acuson had revenues of $437.8 million, up 26% compared with $346.2 million in 1996. The vendor's net income for the year was $22.4 million, compared with a net loss of $10.6 million in 1996, when costs associated with the Sequoia and Aspen launches sent the company into the red.
For the fourth quarter, Acuson's sales were $117.4 million, up 25% over the same period the year before, when the company recorded $93.7 million in revenues. Net income for the most recent period was $6.3 million, compared with a net loss of $2.9 million in the fourth quarter of 1996.
Acuson achieved the revenue growth despite weakness in the Asian and European markets, according to chairman and CEO Samuel Maslak. Market conditions remain positive in 1998, with the U.S. market showing continued strength and the European market stabilizing. Asia will continue to experience difficulties in 1998, but the company remains committed to expansion in the region, Maslak said.
Emerging Perspectives on PSMA PET Radiotracers: An Interview with Kenneth J. Pienta, MD
April 24th 2024In a recent interview, Kenneth J. Pienta, M.D., discussed the impact of piflufolastat F18, current directions in research with other PSMA-targeted radiotracers and future possibilities for the role of PSMA PET in the imaging paradigm for prostate cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.
